All Stories

  1. Additional approaches for identifying non-reproducible cardiac troponin results

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), March 2021, De Gruyter

    pete kavsak

  2. Analytical assessment of ortho clinical diagnostics high-sensitivity cardiac troponin I assay

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), October 2020, De Gruyter

    pete kavsak

  3. High-sensitivity troponin testing months after an acute coronary syndrome: noise or notable results

    Article • Heart, August 2019, BMJ

    pete kavsak

  4. The importance of the methodology and sample matrix when interpreting chromogranin A results

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), August 2019, De Gruyter

    pete kavsak

  5. A Multicenter Assessment of the Sensitivity and Specificity for a Single High-Sensitivity Cardiac Troponin Test at Emergency Department Presentation for Hospital Admission

    Article • The Journal of Applied Laboratory Medicine, July 2019, AACC

    pete kavsak

  6. The Evidence for Laboratory Test–Based Computer Clinical Decision Support Tools on Medication Errors and Adverse Drug Events

    Article • The Journal of Applied Laboratory Medicine, March 2019, AACC

    pete kavsak

  7. Sample matrix and high-sensitivity cardiac troponin I assays

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2019, De Gruyter

    pete kavsak

  8. Perioperative heart-type fatty acid binding protein concentration cutoffs for the identification of severe acute kidney injury in patients undergoing cardiac surgery

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), July 2018, De Gruyter

    pete kavsak

  9. External Quality Assessment Testing Near the Limit of Detection for High-Sensitivity Cardiac Troponin Assays

    Article • Clinical Chemistry, June 2018, AACC

    pete kavsak

  10. Assessing matrix, interferences and comparability between the Abbott Diagnostics and the Beckman Coulter high-sensitivity cardiac troponin I assays

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), June 2018, De Gruyter

    pete kavsak

  11. Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute Coronary Syndrome: Expert Opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Marke...

    Article • Clinical Chemistry, January 2018, AACC

    jordi ordonez-llanos, pete kavsak

  12. Macrocomplexes and discordant high-sensitivity cardiac troponin concentrations

    Article • Annals of Clinical Biochemistry International Journal of Laboratory Medicine, November 2017, SAGE Publications

    pete kavsak

  13. Comprehensive Age and Sex 99th Percentiles for a High-Sensitivity Cardiac Troponin I Assay

    Article • Clinical Chemistry, October 2017, AACC

    pete kavsak

  14. Effect of Repeat Measurements of High-Sensitivity Cardiac Troponin on the Same Sample Using the European Society of Cardiology 0-Hour/1-Hour or 2-Hour Algorithms for Early Rule-Out and Rule-In for Myocardial Infarction

    Article • Clinical Chemistry, April 2017, AACC

    pete kavsak

  15. Total Analytic Error for Low Cardiac Troponin Concentrations (≤10 ng/L) by Use of a High-Sensitivity Cardiac Troponin Assay

    Article • Clinical Chemistry, March 2017, AACC

    pete kavsak

  16. Stressing the Utility of High-Sensitivity Cardiac Troponin Testing in Patients with Possible Cardiac Ischemia

    Article • The Journal of Applied Laboratory Medicine, January 2017, AACC

    pete kavsak

  17. Simulation Models of Misclassification Error for Single Thresholds of High-Sensitivity Cardiac Troponin I Due to Assay Bias and Imprecision

    Article • Clinical Chemistry, December 2016, AACC

    pete kavsak

  18. Rule-In and Rule-Out of Myocardial Infarction Using Cardiac Troponin and Glycemic Biomarkers in Patients with Symptoms Suggestive of Acute Coronary Syndrome

    Article • Clinical Chemistry, November 2016, AACC

    P.J. Devereaux, pete kavsak

  19. Economic Considerations of Early Rule-In/Rule-Out Algorithms for The Diagnosis of Myocardial Infarction in The Emergency Department Using Cardiac Troponin and Glycemic Biomarkers

    Article • Clinical Chemistry, November 2016, AACC

    P.J. Devereaux, pete kavsak

  20. Best Practices for Monitoring Cardiac Troponin in Detecting Myocardial Injury

    Article • Clinical Chemistry, October 2016, AACC

    Amy Saenger, pete kavsak

  21. Adopting ‘ng/L’ as the units for high-sensitivity cardiac troponin assays and commitment by the entire health-care team could be the key for adopting recommendations

    Article • Annals of Clinical Biochemistry International Journal of Laboratory Medicine, July 2016, SAGE Publications

    pete kavsak

  22. Acceptable Analytical Variation May Exceed High-Sensitivity Cardiac Troponin I Cutoffs in Early Rule-Out and Rule-In Acute Myocardial Infarction Algorithms

    Article • Clinical Chemistry, April 2016, AACC

    Dr Andrew C Don-Wauchope, pete kavsak

  23. Hospital Admission and Myocardial Injury Prevalence after the Clinical Introduction of a High-Sensitivity Cardiac Troponin I Assay

    Article • Clinical Chemistry, July 2015, AACC

    pete kavsak

  24. High-Five for High-Sensitivity Cardiac Troponin T: Depends on the Precision and Analytical Platform

    Article • JAMA Internal Medicine, March 2013, American Medical Association (AMA)

    pete kavsak